Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 383

1.

Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.

Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.

J Clin Virol. 2012 May;54(1):61-5. doi: 10.1016/j.jcv.2012.01.012. Epub 2012 Feb 10.

PMID:
22326759
2.

Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.

Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G.

Mol Diagn. 2004;8(1):57-64.

PMID:
15230643
3.
4.

RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.

Cattani P, Siddu A, D'Onghia S, Marchetti S, Santangelo R, Vellone VG, Zannoni GF, Fadda G.

J Clin Microbiol. 2009 Jul;47(7):2136-41. doi: 10.1128/JCM.01733-08. Epub 2009 Apr 29.

5.

Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions.

Baron C, Henry M, Tamalet C, Villeret J, Richet H, Carcopino X.

J Med Virol. 2015 Aug;87(8):1389-96. doi: 10.1002/jmv.24157. Epub 2015 Apr 23.

PMID:
25908062
6.

Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.

Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF.

Gynecol Oncol. 2004 Mar;92(3):873-80.

PMID:
14984955
7.

High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.

Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S.

Oncol Rep. 2012 Jul;28(1):346-52. doi: 10.3892/or.2012.1755. Epub 2012 Apr 3.

PMID:
22484610
8.

Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.

Andersson S, Hansson B, Norman I, Gaberi V, Mints M, Hjerpe A, Karlsen F, Johansson B.

Int J Oncol. 2006 Sep;29(3):705-11.

PMID:
16865288
9.

Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.

Broccolo F, Fusetti L, Rosini S, Caraceni D, Zappacosta R, Ciccocioppo L, Matteoli B, Halfon P, Malnati MS, Ceccherini-Nelli L.

J Med Virol. 2013 Mar;85(3):472-82. doi: 10.1002/jmv.23487. Epub 2012 Dec 26.

PMID:
23280876
10.

Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.

Varnai AD, Bollmann M, Bankfalvi A, Speich N, Schmitt C, Griefingholt H, Kovács K, Klozoris C, Bollmann R.

Oncol Rep. 2008 Feb;19(2):457-65.

PMID:
18202795
11.

Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age.

Molden T, Kraus I, Karlsen F, Skomedal H, Hagmar B.

Gynecol Oncol. 2006 Jan;100(1):95-100. Epub 2005 Sep 8.

PMID:
16153696
12.

Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia.

Andersson E, Kärrberg C, Rådberg T, Blomqvist L, Zetterqvist BM, Ryd W, Lindh M, Horal P.

J Clin Microbiol. 2011 Nov;49(11):3794-9. doi: 10.1128/JCM.00549-11. Epub 2011 Sep 21.

13.

Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction.

Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bültmann B.

J Med Virol. 2004 Sep;74(1):107-16.

PMID:
15258976
14.

Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia.

Tropé A, Sjøborg K, Eskild A, Cuschieri K, Eriksen T, Thoresen S, Steinbakk M, Laurak V, Jonassen CM, Westerhagen U, Jacobsen MB, Lie AK.

J Clin Microbiol. 2009 Aug;47(8):2458-64. doi: 10.1128/JCM.01863-08. Epub 2009 Jun 17.

15.

High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.

Rijkaart DC, Heideman DA, Coupe VM, Brink AA, Verheijen RH, Skomedal H, Karlsen F, Morland E, Snijders PJ, Meijer CJ.

J Clin Microbiol. 2012 Jul;50(7):2390-6. doi: 10.1128/JCM.06587-11. Epub 2012 May 2.

16.

Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.

Silling S, Kreuter A, Hellmich M, Swoboda J, Pfister H, Wieland U.

J Clin Virol. 2012 Apr;53(4):325-31. doi: 10.1016/j.jcv.2011.12.029. Epub 2012 Jan 18.

PMID:
22261122
17.

[Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].

Ardiç N, Oztürk O, Ergünay K, Sezer O.

Mikrobiyol Bul. 2009 Jul;43(3):463-9. Turkish.

PMID:
19795622
18.

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.

Kraus I, Molden T, Holm R, Lie AK, Karlsen F, Kristensen GB, Skomedal H.

J Clin Microbiol. 2006 Apr;44(4):1310-7.

19.

HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.

Pastuszak-Lewandoska D, Bartosińska-Dyc A, Migdalska-Sęk M, Czarnecka KH, Nawrot E, Domańska D, Szyłło K, Brzeziańska E.

Med Oncol. 2014 Mar;31(3):842. doi: 10.1007/s12032-014-0842-6. Epub 2014 Jan 17.

PMID:
24436016
20.

Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.

Cattani P, Zannoni GF, Ricci C, D'Onghia S, Trivellizzi IN, Di Franco A, Vellone VG, Durante M, Fadda G, Scambia G, Capelli G, De Vincenzo R.

J Clin Microbiol. 2009 Dec;47(12):3895-901. doi: 10.1128/JCM.01275-09. Epub 2009 Oct 14.

Supplemental Content

Support Center